Skip Navigation

In the Media

Coverage of department activities and its faculty in the general media.

2018

June

Extreme stress in childhood is toxic to your DNA (opinion) - The Conversation
This opinion piece was written by Daniel R. Weinberger, director of the Lieber Institute for Brain Development and the Maltz Research Laboratories at the Johns Hopkins University School of Medicine. Studies by him and other researchers, he says, have shown that early life stress alters how DNA is packaged, which makes cells function differently than their original mandate.

In search of the Alzheimer's aha! moment AARP
Even delaying the onset of the disease by a few years would be a significant step, says the author of this commentary, Marilyn S. Albert, Ph.D., the director of Cognitive Neuroscience in the department of neurology at Johns Hopkins University School of Medicine and the chair of the AARP Global Council on Brain Health.

Retinal thinning tied to cognitive decline* (study) - Medscape
Also commenting on the study for Medscape Medical News, Esther Seunghee Oh, MD, PhD, associate director of Johns Hopkins Memory and Alzheimer's Treatment Center and associate professor of medicine at Johns Hopkins in Baltimore, Maryland, said the link between retinal thinning and cognitive decline is "exciting" on several levels.

New restrictions on epilepsy drug may do more harm than good - Spectrum
Jennifer Payne, director of the Women’s Mood Disorders Center at Johns Hopkins University in Baltimore, explains why she thinks it’s a bad idea that the EU ban stipulates that women with bipolar disorder must stop taking valproate during pregnancy, even if no other medication works for them. [Valproate is a widely used treatment for epilepsy, bipolar disorder and migraine.]

Even 'mild' high blood pressure risks future dementia – AARP
"Being diagnosed with high blood pressure in, say, your 50s may predict a dementia risk in your 70s and 80s," says neuropsychiatrist Constantine Lyketsos of the Johns Hopkins University School of Medicine. "The mechanism is not clear, but it's probably because moderately ... elevated blood pressure in midlife slowly erodes the blood vessels in the brain and affects the blood supply to the deeper tissues of the brain over the years."

Mental illness: A different kind of #MeToo* (opinion) -Baltimore Sun
The deaths of Kate Spade and Anthony Bourdain are sparking a different kind of #MeToo movement in which others are coming forward and confessing their private pain across CNN, Twitter, Facebook and other media outlets…. I have numerous relatives with bipolar disorder, and I am often one of the few lay people in the crowd at the annual Mood Disorders Symposiums at Johns Hopkins.

Suicide Is Not Just a US Problem, It's a Global Issue – Voice of America
Jennifer Payne, a psychiatrist at Johns Hopkins Medicine, said just because the CDC reported a majority of those who committed suicide did not have a known mental illness, does not mean they didn't have one. "I think it's likely that a majority of cases of suicide are related to a mental health diagnosis," she said. The illness could have been undiagnosed, or because of the stigma associated with mental illness, people may have not sought treatment.

Ketamine cases raise questions over boundaries between police and paramedics - Star Tribune (Minneapolis)
Dr. Solomon Snyder, a neuroscience professor at Johns Hopkins School of Medicine, compared the effects [of ketamine] to those of LSD, and said [the drug] hasn’t been more widely used in depression cases because of its risks. “If you take it, you’ll be out of your head,” he said. “So even if it’s good for depression, you have to do it very carefully.”

Why mental illness is so hard to spot in seniors - U.S. News & World Report
[C]ompared with younger adults and middle-aged adults, adults over age 65 were much less likely to be asked by their primary care physician if they felt tense or anxious and were much less likely to be referred by their primary care physician for mental health specialty care,” says Dr. Susan W. Lehmann, clinical director of the division of geriatric psychiatry and neuropsychiatry and director of the Geriatric Psychiatry Day Hospital at the Johns Hopkins University School of Medicine.

Psychedelics forge connections between neurons (study) - Chemical & Engineering News
About one-third of people with depression do not find relief from their symptoms with current drugs for the disease…. Roland Griffiths, a neuroscientist at Johns Hopkins University School of Medicine agrees that the new study is important. “Almost nothing is known about the neural mechanisms underlying the ability of psychedelics to produce enduring change in moods, attitudes, and behavior,” he says.

U.S. needs to have an ongoing conversation about suicide - How Stuff Works
"I think we need to be having a national conversation," Jennifer Payne, the director of the Women's Mood Disorders Center and an associate professor of psychiatry and behavioral sciences at Johns Hopkins Medicine in Baltimore, says. "I think there's a stigma associated with psychiatric illness that really needs to go away," Payne says.

Mental Health and Well-Being in America - Washington Post Live
Robert Findling, division director of child and adolescent psychiatry, was part of a panel hosted and broadcast by the Washington Post.

Invincibility: Young people and their decisions (video) - WMAR-TV
“The reason that adolescents tend to engage in risk-taking behavior is that they’re more focused on the potential rewards of that behavior. So when they think about driving fast in a car with friends, they’re more focused on their friends having a blast and cheering them on or the thrill of the wind going through their hair,” Dr. Elizabeth Reynolds, a clinical psychologist at Johns Hopkins Hospital, said.

The woman’s libido pill is back – and so is the controversy - Bloomberg
“If you have somebody who’s depressed, and you give them an antidepressant, you don’t want the drug to make them joyous and turn them into a manic state. You want the drug to return them to normal function,” says Leonard Derogatis, an associate professor of psychiatry at Johns Hopkins University School of Medicine. “That’s exactly what the goal is with all the sexual drugs...."

Why eight hours sleep really IS good for you: Less than six or more than 10 hours slumber a night raises the risk of heart disease, stroke and type 2 diabetes - The Daily Mail (U.K.)
Sleeping for more than ten hours a night -- or fewer than six -- may increase the risk of early death, new research has found…. Dr. Patrick Finan from Johns Hopkins University, who was not involved in the study, said: 'Insomnia is shaped by expectation and perception, so it is not surprising that placebos, which implicitly alter expectation, are effective in improving perceptions of sleep.'

Kate Spade’s death ignites concern about rising suicide rate - Kaiser Health News and numerous subscribers
People suffering from serious mental illness are at high risk of suicide, said Dr. Jennifer Payne, director of the Women’s Mood Disorders Center at Johns Hopkins Hospital.... Sometimes, however, friends and families of people with a milder form of bipolar disorder — one that does not induce psychotic behavior — can mistake their condition for depression, Payne said. 

Kate Spade and the Troubling Rise in Female Suicides – Daily Beast
Karen Swartz is the clinical director of the John Hopkins Mood Disorders Center, where she researches people who are working through depression and bipolar disorder and helps train teachers at high schools, who often reach out to her in the aftermath of a tragic high school suicide.

May

 Pregnancy complications might 'turn on' schizophrenia genes, study says - CNN
"The complications that mattered were very serious obstetric complications like pre-eclampsia, intrauterine growth restriction and premature rupture of membranes without induction of labor," said Dr. Daniel Weinberger, director and CEO of the Lieber Institute for Brain Development at Johns Hopkins School of Medicine and a leading author of the new study.

You can inherit schizophrenia. But what happens during pregnancy is key, new study says - Miami Herald
“For the first time, we have found an explanation for the connection between early life complications, genetic risk, and their impact on mental illness and it all converges on the placenta,” Daniel R. Weinberger, the lead investigator on the study from [Johns Hopkins University's] Lieber Institute for Brain Development, said in a statement. Also reported by: StatScientific American

How to help someone who has depression - 9Coach (Australia)
Patients who struggle with mental health can be good at hiding symptoms because they may fear what others think of them…. “Communication becomes problematic because the person is embarrassed to say how they feel, anticipating judgment,” Dr Raymond DePaulo, Jr, [co-director of the Mood Disorders Center at Johns Hopkins University School of Medicine], explained to Everyday Health.

Most preclinical AD doesn't progress to dementia* (study) - MedPage Today
This "methodologically sound study" provides "hope to most with preclinical Alzheimer's that they might live dementia-free even when very old," observed Constantine Lyketsos, MD, MHS, of Johns Hopkins School of Medicine in Baltimore, who was not involved in the study. "What's encouraging here is that people with preclinical Alzheimer's are not destined to develop dementia," Lyketsos told MedPage Today.

Pot holes - Washington Post
(Most neuroscientists don’t believe that LSD is addictive; its potential benefits are being studied at Johns Hopkins and New York University, among other places.)

Yes, you can inherit depression — here’s what that means if you're struggling – Prevention
“Depression is absolutely heritable. It runs in families,” says Shizhong Han, PhD, an associate professor of psychiatry and behavioral sciences at Johns Hopkins Medicine. Any given person with no family history has about a 10 percent risk of developing depression. But if your parents or siblings have the condition? That number spikes to 20 or 30 percent, notes Han.

This will change your mind about psychedelic drugs - Time
The very first study in the modern era of psychedelic research, of any importance, was a 2006 study done at Johns Hopkins by a scientist named Roland Griffiths, a very prominent drug-abuse scientist. He found that what the psychedelics did in about 80% of cases was induce a mystical experience.

Michael Pollan on testing psychedelics as a treatment for depression - CBS News
"I tried psilocybin," he said. "I was very interested in duplicating the research that was going on at Johns Hopkins and NYU. I had a guided psilocybin trip – it was underground because I didn't qualify for any of the trials – and I worked with a guy who was very talented, very professional.

My adventures with the trip doctors - New York Times
Bill Richards, clinical director of the psychedelics-research program at Johns Hopkins and the author of “Sacred Knowledge: Psychedelics and Religious Experiences,” is one of the few surviving links between the first and second waves of sanctioned psychedelic research in America.

7 myths about treating mental illness we need to shut down ASAP – Bustle
[M]ost people can't manage their mental illness via exercise alone. Jennifer Payne, associate professor of psychiatry at Johns Hopkins School of Medicine told Tonic that exercise can do a lot of good for people with various mental health conditions, but it's rarely a stand-alone treatment for someone with a full blown mental health disorder. 

Why kids and teens may face far more anxiety these days - Washington Post
“With (social media), it's all about the self-image — who's 'liking' them, who's watching them, who clicked on their picture,” said Marco Grados, associate professor of psychiatry and clinical director of child and adolescent psychiatry at Johns Hopkins Hospital. “Everything can turn into something negative ... [K]ids are exposed to that day after day, and it's not good for them.”

Depression, memory and small vessel disease intertwine in seniors (study) - MedPage Today
"Evidence is strong that depression is clearly a brain disorder that affects cognitive and emotional functioning through myriad processes, including vascular and inflammatory processes as well as the hypothalamic-pituitary axis, to name a few," added Jin Hui Joo, MD, of Johns Hopkins University in Baltimore, who was not involved in the study.

First, marijuana. Are magic mushrooms next? - Daily Beast
[E]fforts to legitimize hallucinogenic mushrooms come at a time of renewed interest in the potential mental health benefits of psychedelics, including mushrooms, LSD and MDMA (known as ecstasy). Two small studies published in 2016 by researchers from Johns Hopkins University and New York University found that a single large dose of psilocybin, combined with psychotherapy, helped relieve depression and anxiety in cancer patients.

Why you eat more at night — and how to curb your hunger (study) - NBC News
“During the daylight [in hunter-gatherer days], it would have made more sense to prioritize going out to hunt or forage for food. When it was dark, it made more sense to stay close to home and eat,” says lead study author Susan Carnell, PhD, an assistant professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine.

A psychiatrist’s defense of Tully, a controversial new movie about postpartum struggles – Vox
The psychiatrist doing the defending is Dr. Lauren M. Osborne, an assistant professor of psychiatry and behavioral sciences and of gynecology and obstetrics at the Johns Hopkins University School of Medicine. She also is an expert on the diagnosis and treatment of mood and anxiety disorders during pregnancy.

The first diagnosis of autism (audio) - BBC
James Harris, a Johns Hopkins professor of psychiatry and behavioral sciences, talks about his mentor, Leo Kanner, who was a pioneering child psychiatrist at Johns Hopkins and who diagnosed autism in the 1940s.   

April

Are psychedelics the answer to depression and addiction? – Salon
Roland] Griffiths ... a leading Professor of Psychology at Johns Hopkins University School of Medicine in Maryland, one of the best academic institutions in the world ... applied to conduct the very first clinical trial on a psychedelic since the ban a whole generation before. He wanted to give psilocybin, a naturally occurring chemical found inside “magic” mushrooms, to “respectable” citizens who had never used it before, to see if they would have a mystical experience — and to discover what the longer-term consequences, if any, would be.

Are psychedelics the answer to depression and addiction? – Salon
Roland] Griffiths ... a leading Professor of Psychology at Johns Hopkins University School of Medicine in Maryland, one of the best academic institutions in the world ... applied to conduct the very first clinical trial on a psychedelic since the ban a whole generation before. He wanted to give psilocybin, a naturally occurring chemical found inside “magic” mushrooms, to “respectable” citizens who had never used it before, to see if they would have a mystical experience — and to discover what the longer-term consequences, if any, would be.

The funeral director's opioid scare mission: Can fear help stop addiction? -The Guardian
“Scared straight comes from a good place, because I think a lot of times family members and friends just feel desperate and they are trying to make a big impact,” says Kelly Dunn, an associate professor of Psychiatry and Behavioral Sciences at Johns Hopkins University. “But they don’t realize that perhaps it’s not a moral weakness or personality – a choice.”

75 Years After First LSD Trip, Psychedelic Science is Making a Comeback - Seeker
All that work finally seems to be paying off as psychedelics, including LSD, are experiencing a full-blown research renaissance. The tipping point came in 2006 with an article published by Roland Griffiths, a respected psychopharmacologist at Johns Hopkins University School of Medicine, which showed that a single dose of psilocybin — also first isolated by Albert Hofmann from psychoactive mushrooms in Mexico — can trigger “mystical experiences” that have a lasting positive psychological effect.

The good, the bad, and the maybe, about kratom - Healio
Jack E. Henningfield, PhD, is an adjunct professor at Johns Hopkins University and vice president for research, health policy and abuse liability at Pinney Associates, told Healio Family Medicine FDA regulation on kratom is “vital” and that regulation of the substance as a dietary supplement was a viable approach to keep kratom available with some regulatory oversite.

Why does it take so long to diagnose bipolar disorder? - NBC News
Stigma makes it even more difficult for people to get help. “The average length of time between a person’s first episode and getting the correct diagnosis is eight years,” said Kay Redfield Jamison, a professor of psychiatry at the Johns Hopkins School of Medicine and author of “Touched with Fire: Manic-Depressive Illness and the Artistic Temperament.” “That’s a very large chunk of life given that bipolar disorder most often hits in late adolescence or in the early 20s,” Jamison said.

What is bipolar II? (video) – WTTG-TV (D.C.)
Erica Richards, M.D., Ph.D., chair and medical director of the Department of Psychiatry and Behavioral Health at Sibley Memorial Hospital, explains bipolar 2, which singer Mariah Carey has just announced she suffers from. Richards also discusses treating and managing the disorder

Mariah Carey says she has bipolar disorder (video) - WUSA-TV (D.C.)
Erica Richards, M.D., Ph.D., chair and medical director of the Department of Psychiatry and Behavioral Health at Sibley Memorial Hospital, defines bipolar disorder and explains the difference between bipolar 1 and bipolar 2. She also encourages people who think they might be bipolar to start a conversation with their medical care provider.

New Alzheimer's definition and the clinician* - MedPage Today
Kostas Lyketsos, MD, MHS, Professor of Psychiatry and Behavioral Sciences, Johns Hopkins Medicine, was among the top Alzheimer's specialists invited to discuss [for this article] the new definition and the issues it raises.

Opioid addiction treatment with medicine works best. Why don't more young people get it? - Philadelphia Inquirer
Young opioid users often have other mental-health issues, and many abuse other substances, as well. “They are a chaotic population,” said Marc Fishman, an assistant professor of psychiatry at Johns Hopkins University School of Medicine and medical director of the Maryland Treatment Centers and Mountain Manor Treatment in Baltimore. “They [think they] are invincible. They’re not well-engaged in treatment of any kind.”

We’re beginning to learn how moms’ antidepressants can affect fetuses (study) - Vox
According to Lauren Osborne, the assistant director of Johns Hopkins Women’s Mood Disorders Center, who has analyzed the research, most studies compare depressed pregnant women who were taking antidepressants to healthy pregnant women — so there may be more that differs between the two groups than just the use of antidepressants.

Emmitsburg woman successfully treats depression through a little-known treatment - Frederick News-Post
[T]he little-known therapy [transcranial magnetic stimulation] is heralded by many psychiatrists as one of the most effective ways of treating depression in patients who show resistance to medications. “In our clinical experience, we’re seeing response rates of 50 to 60 percent and remission rates of 30 to 40 percent,” said Dr. Irving Reti, a psychiatrist and director of the Brain Stimulation Program at Johns Hopkins University.

Many people taking antidepressants discover they cannot quit - New York Times
“What you see is the number of long-term users just piling up year after year,” said Dr. Dr. Mark Olfson, a professor of psychiatry at Columbia University. Dr. Olfson and Dr. Ramin Mojtabai, a professor of psychiatry at Johns Hopkins University, assisted The Times with the analysis.​

March

7 Xanax side effects you should know about - Women’s Health
“If [Xanax is] taken regularly, even for a matter of weeks, it can be problematic to stop cold-turkey,” says Joseph Bienvenu, MD, Ph.D., an associate professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine.

The science behind nervous sweating and how to put an end to it - Health24
“Involuntary sweating is like your body betraying you,” says Dr Carisa Perry-Parrish, a psychologist at the Johns Hopkins Center for Sweat Disorders in Baltimore. We want to appear confident, but our bodies scream, “I cannot do this!” Then we go from sweating because we’re stressed to stressing because we’re sweating, says Perry-Parrish.

New grant allows local treatment center to pair physical health and substance abuse services - Frederick News-Post
Diabetes, asthma, heart disease and high blood pressure are frequently seen among clients who enter the [substance abuse treatment] program. Infections such as HIV and hepatitis are also experienced frequently by intravenous drug users, said Dr. Kenneth Stoller, a psychiatrist and the director of the Johns Hopkins Broadway Center for Addiction.

Perinatal mood and anxiety disorders: Redefining postpartum depression -  MD magazine
Lauren M. Osborne, MD, assistant director of the Johns Hopkins Women’s Mood Disorders Center and assistant professor of psychiatry and behavioral sciences at Johns Hopkins School of Medicine, is an expert in the diagnosis and treatment of mood and anxiety disorders during pregnancy and postpartum....  “It’s an enormous transition from being a free person to being a person with a child,” Osborne said. “The biggest risk factor for developing postpartum depression is depression during pregnancy, but other risk factors are poor social support … adverse life events, and lack of sleep.”

If you’ve met aliens while on DMT, these scientists would like to hear from you (study) – Vice
The prestigious medical university at Johns Hopkins wants to know if you’ve ever taken so much dimethyltryptamine (DMT) that you’ve broken through reality and met the benevolent machine elves that live in the center of the universe. Researcher Roland R. Griffiths is the neuroscientist in charge of the study and he’s been on the forefront of scientific research into psychedelic experiences for decades.

A brush with madness (video) - CBS News
"Study after study after study has shown that there is a disproportionate rate of mood disorders, in particular, in highly-creative people," said Kay Redfield Jamison, a professor of psychiatry at Johns Hopkins University School of Medicine, [who] is considered a leading expert on mood disorders in artists.

Enhanced privacy for substance abuse patients under debate again in Congress - Modern Healthcare
Dr. Eric Strain, director of the Center for Substance Abuse Treatment and Research at Johns Hopkins, testified on behalf of the Mullin bill, noting that even though providers may often know from their patients that they been through addiction treatment, they can still be hamstrung by not knowing what that treatment was.​

Ageism in Medicine Must Stop, Experts Say – Medscape (sign in required to view)
An article based on Susan Lehmann-led session on Ageism in Medical Education at the recent meeting of the American Association for Geriatric Psychiatry(AAGP).

LSD alters the neural response to music in a number of brain regions, study finds – PsyPost
New research illuminates how the psychedelic drug LSD changes our perception of music. The study found that LSD altered the neural response to music in brain regions associated with auditory processing, memory, emotion, and self-directed thought.... “​I have always been fascinated by emotion, memory, and altered states of consciousness.... ” said study author Frederick Barrett of Johns Hopkins University School of Medicine.

Lurasidone (Latuda) gets FDA nod for bipolar depression in kids* Medscape
"We know that children who have been diagnosed with bipolar depression can be at risk for poor school performance and impairments in social functioning. The FDA approval of this medicine for the treatment of pediatric patients with bipolar depression is significant for several reasons," commented Robert Findling, MD, director of child and adolescent psychiatry, Johns Hopkins University School of Medicine. Also covered in Clinical Psychiatry News

Breast cancer incidence higher in women with schizophrenia (study) – Healio
“Because schizophrenia has been associated with lowered risks of many types of cancer, including colorectal cancer, malignant melanoma and prostate cancer, it has been hypothesized that the genetic factors involved in the pathogenesis of schizophrenia may be protective against cancer,” Chuanjun Zhuo, MD, PhD, department of psychiatric laboratory, Tianjin Medical University, China, and Patrick Todd Triplett, MD, department of psychiatry and behavioral sciences, Johns Hopkins School of Medicine, wrote. “However, the association between schizophrenia and breast cancer remains uncertain.”

Denver may get to vote on whether to make magic mushrooms legal - Colorado Public Radio
[Kevin Matthews, who helps lead the campaign and helped draft the initiative] points to a study by Johns Hopkins University that found psilocybin users dealing with cancer-related stress reported lasting positive effects one year later. A New York University study produced similar results.  

February

Targeting mental Illness won’t prevent mass shootings (Opinion) – Baltimore Sun
Op-Ed piece by part-time faculty member, Annette Hanson, M.D.

6 ways to prevent your smartphone from making you feel dumber - Oprah
Smartphones ... hamper our ability to recall things by overwhelming our mind with distractions, says Susan Lehmann, MD, clinical director of geriatric psychiatry and neuropsychiatry at the Johns Hopkins University School of Medicine. "When you use these devices, you're often switching quickly between topics or conversations," she says. "That rapid change in focus can prevent an idea or thought from sufficiently registering in your memory."

Doctors voice concern about opioid addiction in women, and the impact on newborns - Tampa Bay Times
"Opiate use has historically been predominantly by men, but we’ve seen that gap narrow significantly in the past 10 years," said Dr. Kelly Dunn, an associate professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine in Baltimore. Dunn is in Tampa Bay this week joining other doctors from Johns Hopkins and its local All Children’s pediatric hospital for a series of events titled "A Woman’s Journey."

FDA serotonin syndrome warning erroneous? (study) - Medscape
This study demonstrating a "low risk of serotonin syndrome with [selective serotonin reuptake inhibitors] and [selective norepinephrine reuptake inhibitors] and the triptans is actually very important," Jennifer Payne, MD, director, Women's Mood Disorders Center, Johns Hopkins School of Medicine, told Medscape Medical News. "Since both antidepressants and triptans are commonly used medications, knowing that there is a low risk of an adverse reaction is reassuring...." said Payne.

My eating disorder made me feel like a feminist fraud - Marie Claire
Several studies, including one from Johns Hopkins University, frame chewing and spitting as a symptom of anorexia, bulimia, and/or OSFED (Other Specified Feeding and Eating Disturbances), and suggest that it may be an indicator of disease severity.

Vaccines against addictive drugs push forward despite past failures - Chemical & Engineering News
Although interest from the pharmaceutical industry has been intermittent, experts in substance abuse treatment are guardedly hopeful. “The vaccines seem very promising, and they’re novel, providing a different mechanism to prevent substance abuse,” says Kelly E. Dunn, who studies opioid use disorders at Johns Hopkins University School of Medicine. “But there is still a lot of work to do.”

Excessive alcohol use linked to early-onset dementia risk (study) – CNN
Although many studies have shown a strong association between excessive alcohol use and dementia, this study is unique in its findings about early-onset dementia, according to Dr. Kostas Lyketsos, a neuropsychiatry professor and director of the Johns Hopkins Memory and Alzheimer's Treatment Center who was not involved in the study. "That is rather unique," Lyketsos said. "It does remind us that alcoholics have shorter life expectancies.”

The perplexing semantics of anosognosia - Psychology Today
Is anosognosia [unawareness of illness] after stroke the same as anosognosia during psychosis? .... Dr. Solomon Snyder at Johns Hopkins, a renowned neuroscientist ... told me, "In my personal experience, a substantial number of psychiatric patients lack appreciation that they are disturbed and so merit the anosognosia designation.

Running away or righting the way: Is psilocybin a viable psychiatric treatment?- MD magazine
"[T]here are some leading institutions in the United States that are all about [this work],” [said Charles L. Raison, MD, director of Multidisciplinary Association for Psychedelic Studies]. “If you look at the places that are doing psilocybin work, they are not second rate. They’re Yale, Johns Hopkins, the University of California at San Francisco, and NYU. These are top, top places....

ECT for self-injurious behavior in autism: A new indication - Psychiatric Times
ECT [electroconvulsive therapy] has been documented as nothing short of lifesaving for many children and young adults with autism spectrum disorder who were previously wholly incapacitated by SIB [self-injurious behavior], say the writers of this commentary. [Among them: Lee Elizabeth Wachtel, MD, Associate Professor of Psychiatry, Johns Hopkins School of Medicine.]

Why do so few docs have buprenorphine waivers? - MedPage Today
Even among doctors who have buprenorphine waivers, utilization is low. In a 2017 survey-based study, Kelly Dunn, MS, PhD, of Johns Hopkins University in Baltimore saw physicians were concerned about not having enough time or resources to help patients with opioid addiction. "The research suggested that physicians either don't feel informed enough, or aren't comfortable with, the idea of prescribing," she said.

Post-Partum Depression: A Clinical, Not Legal, Issue – MedPage today
A nurse who called law enforcement on a patient out of concern that she could harm her newborn infant could be a sign of a wider problem related to provider education about post-partum depression, experts said.... "It's easy for us to vilify, and point to all the things that went wrong in that situation -- and there were many -- but it points to the fact that our frontline providers need more education in this area," Lauren Osborne, MD, assistant director of the Johns Hopkins Women's Mood Disorders Center in Baltimore, told MedPage Today.

Homeless. Addicted to heroin. About to give birth. - Mother Jones
Unlike many in her position, [Gina] DiStefano had a place to go. A sex worker had told her about the Center for Addiction and Pregnancy at Johns Hopkins, a hulking brick building on the outskirts of Baltimore. The center, known as CAP, is one of the few places in the country that offers pregnant drug users comprehensive support.

Experts provide tips on diagnosing, treating concussions - Healio
To help primary care physicians make accurate, timely diagnoses of concussions, Healio Family Medicine asked neurological, orthopedic, sports medicine and psychiatry experts to provide information on concussion symptoms, treatments, broaching the subject with patients, and more. Among the experts: Jennifer M. Coughlin MD, assistant professor, department of psychiatry and behavioral sciences, Johns Hopkins Medicine.

Depression course for teens gets high marks - Healthline
Dr. Karen Swartz, an associate professor of psychiatry and behavioral sciences at Johns Hopkins University, has developed a proactive way to get high school students thinking about the seriousness of depression.

8 questions to ask yourself if you think you might have a drinking problem - Women's Health
Does your social life revolve around alcohol? ... Women with a drinking problem tend to lose interest in hobbies or people they once enjoyed because they'd rather go where the alcohol is. “You’re planning your social life and your time around drinking,” says licensed clinical alcohol and drug counselor Beth Kane-Davidson, director of the Addiction Treatment Center at Suburban Hospital in Bethesda, Maryland.

New hope for Alzheimer's sufferers (study) - AARP
Previous work with [deep brain stimulation] and Alzheimer’s led by the University of Toronto and Johns Hopkins Medicine focused on stimulating memory circuits. “We saw slower decline in some individuals,” notes Gwenn Smith, a neuropsychologist at Johns Hopkins and a coauthor of the study, and she says that an increase in brain metabolism over one year was observed.

January

Binge eating at night? Your hormones may be to blame  - New York Times
“There’s more opportunity to eat in the evening, but this study is showing that hormonal responses are setting them up to do this,” said Susan Carnell, an assistant professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine who was a first author of the study. It’s not clear whether these hormonal patterns precede and cause the binge eating behaviors or are conditioned by an individual’s eating habits, Dr. Carnell said.

Is brain stimulation the future of Alzheimer’s treatment? – Healthline
Deep brain stimulation is thought to affect the activity and interaction of neurons. In previous studies, said Gwenn Smith, PhD, a professor of psychiatry and behavioral sciences at Johns Hopkins Medicine, “deep brain stimulation not only increased brain metabolism in specific regions, but also increased the connections between them, what’s known as ‘functional connectivity.’”

Can pot cause hallucinations? Report of officers who allegedly ate edibles fuels debate - CBC (Canada)
Ryan Vandrey, associate professor of psychiatry and behavioural sciences at Johns Hopkins Medicine in Baltimore, says there have been very clear demonstrations and scientific studies proving [that marijuana can cause hallucinations]. "Folks tend to be more prone to have hallucinations if they have a family history of psychosis, but there have been cases, even one recently in my laboratory, where somebody without a family history of psychosis has had hallucinations following acute dosing with cannabis," he said. 

Citing deaths of lab monkeys, F.D.A. ends an addiction study - New York Times
Jack Henningfield, professor of behavioral biology at Johns Hopkins School of Medicine, disagreed with the decision to stop the study. “These studies are done to address really serious questions about the nature of tobacco addiction,” Dr. Henningfield said. ‘‘This is research in serious service to humanity.

Mixing magic mushrooms and meditation has long-term benefits, Johns Hopkins study finds - Big Think
[R]esearchers from the Johns Hopkins University School of Medicine wanted to see how “quantum change experiences” induced with the help of psilocybin (the psychoactive substance in magic mushrooms) combined with regular spiritual practices (like meditation, journaling, awareness) resulted in the overall well-being of healthy volunteers over the course of six months.

How daytime stress turns into nighttime snacking – Forbes
"Our findings suggest that evening is a high-risk time for overeating, especially if you're stressed and already prone to binge eating," says Susan Carnell, Ph.D., assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, and the study's first author.

Education is a simple yet effective tool for teens fighting depression – Inverse
[R]esearchers from Johns Hopkins University in Baltimore [have] created the Adolescent Depression Awareness Program (ADAP), which marries student curriculums with training for health and school-based professionals in order to deliver a core message to the public: depression is a treatable medical illness and people should feel empowered to seek help.

Why evenings may be a dangerous time for dieters – HealthDay
The small study suggests that you're more likely to overeat in the evening -- especially if you're feeling stressed. "The good news is that having this knowledge, people could take steps to reduce their risk of overeating by eating earlier in the day, or finding alternative ways to deal with stress," said study lead researcher Susan Carnell. She's an assistant professor of psychiatry and behavioral sciences at the Johns Hopkins School of Medicine in Baltimore.

Are new brands of strong coffee boosting heart palpitation risks? – Newsmax
"For the same amount of coffee [Black Insomnia vs. Starbucks], you will get double the amount of caffeine," said Mary Sweeney, who researches the effects of caffeine at Johns Hopkins School of Medicine. "This makes it easier to consume more caffeine than you intend to and effects can range from mild to severe, for example, jitteriness, nervousness, restlessness and trouble sleeping. The most serious effect would be cardiac arrhythmia (irregular heartbeat)."

The truth about electrical brain stimulation – Lifehacker
“You’re affecting large swaths of neurons that then have downstream effects in their relationship with other neuronal populations and networks, so where you place the electrodes is really critical,” says Tracy Vannorsdall, a neuropsychologist at Johns Hopkins University School of Medicine. “We know that very small changes in the electrode montage—where we’re placing them on the brain—can have significant different effects in terms of cognitive outcomes.”

Self-report screening questionnaires overestimate prevalence of depression (analysis) - Healio
Jennifer L. Payne, MD, associate professor of psychiatry, and director, Johns Hopkins Women’s Mood Disorders Center, Johns Hopkins School of Medicine, describes the analysis as “a thoughtful discussion of the pros and cons of screening instruments for depression” and adds that “[t]he paper makes several important points including that screening instruments should not be used to estimate prevalence….”

Some health providers now treat depression with magnets instead of pharmaceuticals - North Bay Business Journal (Santa Rosa, Calif.)
[Transcranial magnetic stimulation] was first developed in 1985 and was approved by the FDA in 2008. Though not completely mainstream, the treatment is covered by most insurances and is used by the Mayo Clinic, the Johns Hopkins Brain Stimulation Program, and several clinics throughout the North Bay, including Brainefit, in Davis. 

Second Opinion: Eating Disorders - WXXI-TV
Using real-life medical cases, specialists grapple with diagnosis and treatment options to give patients and TV viewers up-to-date, accurate medical information. In this episode, Angela Guarda, M.D., director of the Eating Disorders Program at Johns Hopkins Hospital, is on a panel discussing eating disorders. View video

Expert Panel Unveils Recommendations for Home-Based Dementia Care (Press Release)
A panel of leading researchers and policy experts, funded by BrightFocus Foundation and led by Johns Hopkins University researchers, has released five key recommendations for public and private sector leaders to better support people with dementia living in their own home. The panel noted that the vast majority of people with dementia prefer to remain in their own home, and that home-based dementia care can be less costly to families and taxpayers than care provided through nursing homes or other long-term care facilities.

How opioids kill - Scientific American
When a person smokes, snorts or injects an opioid, the substance enters the bloodstream, then the brain. There it can act on mu-opioid receptors, says Eric Strain, director of the Center for Substance Abuse Treatment and Research at Johns Hopkins University. “Once the drug binds to those opioid receptors and activates them, it sets off a cascade of psychological and physical actions; it produces euphoric effects, but it also produces respiratory-depressing effects,” Strain says.

The Teenage Mental Health Crisis: Finding Meaning in Arts Education - WYPR-FM
Dr Karen Swartz, talk about this exchange and the things that can go right or wrong at a moment like this when a teenager comes to a parent with this sort of issue. "One of the biggest challenge parents have is not really understanding enough about depression to take it seriously. Given the choice between thinking well my child's having a hard time or they are having a little bit of a rough patch versus they have potentially a life-threatening illness, they're not going to chose the second. They want to think that they're ok and that it's going to pass with time. The average adult doesn't know much about depression and so, they're not recognizing the signs. [Joelle] just gave a beautiful description of so many of the symptoms that young people have, but you could right them all off. You could understand them all and that's the problem. The way we make a diagnosis is to look for those coming together and staying, but I would say most parents aren't armed with the information to say, 'Oh my goodness, this is the serious kind of depression.'"

Some health providers now treat depression with magnets instead of pharmaceuticals
North Bay Business Journal (Santa Rosa, Calif.)
[Transcranial magnetic stimulation] was first developed in 1985 and was approved by the FDA in 2008. Though not completely mainstream, the treatment is covered by most insurances and is used by the Mayo Clinic, the Johns Hopkins Brain Stimulation Program, and several clinics throughout the North Bay, including Brainefit, in Davis. 

People have spent centuries trying to prove caffeine is dangerous, but the science suggests otherwise – Quartz
If caffeine-use disorder became a recognized diagnosis, it would appear alongside opioid-use disorder, tobacco-use disorder, and other often-deadly addictions. This could “minimize the severity of other substance-use disorders,” says Maggie Sweeney, a psychiatry instructor at Johns Hopkins University

Regional and national acceptance of medical cannabis reaches historic highs - Chicago Tribune
Prestigious medical centers and teaching hospitals around the world and in the United States such as Johns Hopkins and other universities have received initial funding to begin baseline data collection on registered medical cannabis patients from around the country using medical marijuana to treat the symptoms associated with their qualifying medical conditions.

2017

December

Child sex dolls, the newest outlet for pedophiles, must be banned - The Hill
[E]emerging psychology on the topic says these obscene dolls encourage abuse of real children. Peter Fagan from the Johns Hopkins School of Medicine recently told The Atlantic that child sex dolls likely have a “reinforcing effect” on pedophiles, and “in many instances cause [the urge] to be acted upon with greater urgency.”

Coping with seasonal depression (audio) - WYPR-FM
Today on Midday, ways to cope with grief, depression, and anxiety during the holidays. [Guests include] Dr. Mark Komrad, a senior supervising psychiatrist and Ethicist-in-Residence at Sheppard Pratt Hospital in Baltimore. He’s also a faculty member in the departments of Psychiatry at Johns Hopkins and at the University of Maryland.

'Phenomenal' trial results may lead to a treatment for Huntington's disease, experts say - Washington Post
The good news for Huntington's patients is the hope that the drug might even reverse the progression of the disease. “What's really interesting in animal studies, if you stop the production of the mutant protein, not only does progression stop, but the brain starts to heal itself,” said Christopher Ross, director of the Huntington's Disease Center at Johns Hopkins Medicine, who was not involved in the research. “Which means there might be improvement.”

Peter Thiel is betting on magic mushrooms to treat depression — and he's not the only one - Business Insider
Usona, a non-profit company based in Madison, Wisconsin, is also in the planning phases of studies of psilocybin for depression and anxiety. Its advisors include three American researchers who were involved in Clark Martin's clinical trial from Johns Hopkins University and New York University.

Hopkins cardiologist says love is more than a matter of the heart - Baltimore Sun Dr. Peter V. Rabins, a professor of psychiatry at Johns Hopkins and the University of Maryland, Baltimore County, is the author of “The Why of Things,” a 2013 exploration of causality in science and in life. “In this age of hookup apps, and with all the stuff about sexual harassment that has come out in the ...

Can Social Media Help Improve ADHD Treatments? – U.S. News and World Report
Dr. David W. Goodman, assistant professor in the department of psychiatry and behavioral sciences at Johns Hopkins School of Medicine and the director of the Adult Attention Deficit Disorder Center of Maryland, calls the research “interesting and very sophisticated,” touting its ability “to parse out language” used on Twitter and yield high prediction rates when picking out ADHD individuals versus non-ADHD individuals.

This is a scientifically determined playlist for tripping - Inverse
The swelling soundscape surrounding you is the artistry of psychologist Bill Richards, Ph.D., who developed the playlist specifically for your psychedelic trip. Richards works with Roland Griffiths’s lab at Johns Hopkins University, where patients get more than just conventional medicine.

There Once Was a Girl: Against the false narratives of anorexia. - Slate
Though their effect is hard to quantify, “a lot of war stories and memoirs out there … glorify the specialness and suffering of anorexia,” says Dr. Angela Guarda, director of the Johns Hopkins Eating Disorders Program. “Anecdotally, patients often acknowledge that these writings romanticize the disorder,” and that “reading them can be triggering and worsen their ED.”

Fundraising stamps will benefit Alzheimer's disease research (video) - WBAL-TV
The United States Postal Service is doing its part to find a cure for Alzheimer's disease. Officials held a ceremony at Johns Hopkins [Bayview Medical Center] to unveil the Alzheimer's semi postal fund-raising stamp. It will benefit the Department of Health and Human Services and their efforts to find a cure

November

Mount Airy woman recognized at Alzheimer's awareness stamp dedication - Carroll Count Times
Thursday’s ceremony included comment from many, including Johns Hopkins Bayview Medical Center President Dr. Richard Bennett and Congressman Elijah Cummings, D-District 7.

USPS dedicates Alzheimer’s fundraising stamp - WCBD News 2
Postmaster General Megan J. Brennan dedicated a stamp today to fund research to help find a cure for one of the top 10 leading causes of death — Alzheimer’s. The first-day-of-issue dedication ceremony for the Alzheimer’s Semipostal Fundraising stamp took place at Johns Hopkins Bayview Medical Center in Baltimore.

Redefining age (audio; 21:35) - WYPR-FM
[The show's host says to author Ann Kaiser Stearns]: You write that there's a learning curve to caregiving, and you quote Dr. Ray DePaulo, the former head of psychiatry at Johns Hopkins Medicine, about ways to avoid what you call "the catastrophic reaction."

Self-harm rises sharply among tween and young teen girls, study shows - Los Angeles Times
In a November 2016 study chronicling the rise in depression among young girls, a team led by Johns Hopkins psychiatrist Ramin Mojtabai noted that adolescent girls appear to be coming under increasing stress. As an example, Mojtabai and his team wrote that cyberbullying may have increased more dramatically among girls than boys.

What is ephebophilia? Some say attraction to teens is not the same as paedophilia - International Business Times
"The average man refrains from sex with a child not only because he's a moral person but also because a child does not tempt him sexually," said [Fred] Berlin, founder of the Sexual Disorders Clinic at the Johns Hopkins Hospital. "Ephebophilia is a condition in which a person is attracted not to prepubescent children but to children or adolescents around the time of puberty, basically teenagers. Most men can find adolescents attractive sexually, although, of course, that doesn't mean they're going to act on it."

A change of mind: Scientists are learning to predict psychosis years in advance — and possibly prevent -The Scientist
[W]hy does one person with these early signs develop psychosis and not another? Brain studies have yielded some clues. In healthy kids, "the brain dynamically changes" during adolescence, says Akira Sawa, a psychiatrist at Johns Hopkins University in Baltimore, Maryland. 

Why can’t Lucile Packard Children’s Hospital Stanford offer care for mentally ill kids? - San Jose Mercury News
Model inpatient youth psychiatric care is provided at other U.S. hospitals, including Johns Hopkins, which delivers inpatient diagnosis and treatment for ages 5 to 17.

The U.S. Postal Service is taking on Alzheimer’s with a new stamp - Washington Post
The first-class stamp, which shows someone placing a hand on the shoulder of an elderly woman, hints at the hope and companionship that caregivers, researchers and an aware public can bring.... The stamp will be dedicated at a ceremony at the Memory & Alzheimer’s Treatment Center at Johns Hopkins’s Bayview campus in Baltimore on Nov. 30.

This doctor might have the answer to the fentanyl crisis - Vancouver magazine
The last five or so years have seen a resurgence of clinical interest in psychedelics — the old hippie drugs that can open what Johns Hopkins psychologist Roland Griffiths calls a “spiritual window” through which deep insight might flow.

Why powerful men make women watch them masturbate - San Diego Union-Tribune
Driven by strong, recurrent sexual urges, exhibitionists act on a self-deceptive fantasy that the witness might enjoy the experience, said Frederick Berlin, the director of the Sex and Gender Clinic at Johns Hopkins Medicine in Baltimore. When the witness responds negatively, the exhibitionist often feels intense regret, shame and self-disgust, said Berlin, an associate professor of psychiatry and behavioral sciences.​

How caring for a sick pet can raise your risk of depression - U.S. News & World Report
Caring for a sick pet has many parallels with providing care to human loved one, says Dr. Susan W. Lehmann, clinical director of the division of geriatric psychiatry and neuropsychiatry and director of the Geriatric Psychiatry Day Hospital at the Johns Hopkins University School of Medicine.

October

Monthly shot for opioid addiction might be as effective as daily medication - Healthline News
“One of the biggest risk factors for people when they detox is that in the 30 days after, they are no longer physically dependent on opiates. They have a very high risk of relapsing to opiates,” Kelly Dunn, PhD, an associate professor of psychiatry and behavioral sciences at Johns Hopkins Medicine, told Healthline.

The Most Lethal Means: Guns and Suicide – WYPR
Paul Nestadt, MD, postdoctoral fellow, is interviewed.  His recent research paper compares urban and rural suicide rates in Maryland. Ramin Mojtabai, MD and Patrick Triplett are also authors on that paper. 

How to talk to kids about the deadly New York City truck attack - ABC News
Joan Kaufman, a professor of psychiatry and child and adolescent psychiatry at Johns Hopkins School of Medicine, said having conversations about Tuesday’s attack with children of all ages -- including as young as preschool -- is a must for parents. “There might be the feeling they want to protect their kids and not talk to them about it, but children are going to find out,” she said. “It’s better if information about the event comes from the parents.”

The caffeine 'detox': How and why to cut back on your daily fix - CNN
"Caffeine is the most commonly consumed psychoactive drug," said Mary M. Sweeney, an instructor who researches caffeine's effects on individuals in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. "When we consume caffeine, it has positive effects on mood and alertness, and people like these beneficial effects."

Why we all have clutter and how to get rid of it - Psych Central
I do not feel equipped to give advice here when I’m tripping over piles of books on the floor of my bedroom. But I like the behavioral tips offered by Dr. Gerald Nestadt, director of the Johns Hopkins OCD clinic, in an issue of The Johns Hopkins Depression & Anxiety Bulletin.

Betty Jarratt, psychiatric liaison at Hopkins Hospital - Baltimore Sun
Betty Jarratt, a former psychiatric liaison at Johns Hopkins Hospital … died Thursday of respiratory failure at The Cedars, a Portland, Maine, retirement community. She was 94…. After Ms. Jarratt was divorced in 1966, she moved to Baltimore when she was selected by Hopkins Hospital to work with Dr. Joel Elkes, a noted expert on brain chemistry and early psychiatric drugs.

Will psychedelic therapy transform mental health care? - NBC News
In 2016 … a Johns Hopkins study and a concurrent New York University study found that about 80 percent of cancer patients showed clinically significant decreases in depressed mood and anxiety even six months after receiving one to two psilocybin treatments.

September

You can't cure depression by working out – Vice
"People experience anxiety, no doubt about it, but [most] don't have an anxiety disorder," says Jennifer Payne, an associate professor of psychiatry and behavioral science at Johns Hopkins School of Medicine. "Yoga is fabulous and can be great for anxiety, but it's not going to cure an anxiety disorder."

Interrupted sleep can prevent slow wave sleep and wreck your mood  -Today
“When sleep is disrupted several times during the night you may never get to slow wave sleep,” explains the study’s lead author, Patrick Finan, an assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine. And that, Finan says, may be what makes all the difference in a person’s mood the next day.

Parental age ups rate of new mutations passed to children  - Spectrum
The findings provide one possible explanation for the increased risk of autism among children born to older parents. But it is still unclear how much of the risk the increased mutation rate explains, says Daniel Weinberger, professor of psychiatry, neurology and neuroscience at Johns Hopkins University in Baltimore, who was not involved in the study.

Matter of Fact: State of Addiction (video; 33:28) - WBAL-TV
This primetime, one-hour special that addresses America's opioid epidemic includes the story of a Baltimore heroin user who has been treated at, among other places, Johns Hopkins’ Broadway Center for Addiction. A woman who has been supportive of his recovery treatment says the Broadway Center “has really taken the time to diagnose him and treat him as a person.”

Psychiatric services from pages to practice (audio; 9:15) - Psychiatric Services
The hosts of this podcast discuss a recent report by Stanislav Spivak, medical director, Johns Hopkins’ Mobile Treatment Services of Community Psychiatry, on the effects of direct-to-consumer advertising on medication adherence.

America’s Opioid Epidemic - Search for Solutions – The Hill
A panel discussion featuring Ken Stoller, M.D. Director of the JH Broadway Center for Addiction

Changing the dialogue about mental illness in black community - Afro American
Resources are available. Maryland boasts a higher doctor to patient ratio than the national average. Organizations like The Simon Life and Wellness Center and All Walks of Life, among others, cater to Baltimore’s underserved populations. Inpatient and outpatient programs that accept Medicaid are available at Johns Hopkins Hospital and the University of Maryland Medical Center.

Alzheimer’s linked to low brain chemical count​ - National Enquirer
Research carried out by Gwenn Smith, a psychiatry professor at the Johns Hopkins University School of Medicine, examined the levels of serotonin in the brains of 56 participants.... Scans found participants with [mild cognitive impairment] had up to 38 percent less serotonin than healthy participants of the same age. The findings suggest the brain chemical may drive the illness rather than simply being its by-product.

2 scientists are locked in a race to develop a groundbreaking vaccine for heroin, but it might not be a 'magic bullet' - Business Insider
While the Obama administration made administrative changes to increase the number of prescribers administering buprenorphine last year, a study conducted by the Johns Hopkins School of Medicine earlier this year found that only 44% of physicians who had obtained a waiver to prescribe buprenorphine were doing so at full capacity.

Hobart man seeks 'chemical castration' instead of prison time - Chicago Tribune
[Michael] Bessigano asked that the court consider the time he's spent incarcerated and release him on the condition that he undergoes chemical hormone treatments using the drug Depo-Lupron, that would reduce his testosterone levels.... Fred Berlin, an associate professor at the Johns Hopkins University School of Medicine, evaluated Bessigano during a July interview and wrote in a letter that the hormone treatment could prove effective.

The Secret To Chronic Happiness As You Age - Kaiser Health News
“You have to be willing to accept your new reality — and move forward,” said Dr. Susan Lehmann, director of the geriatric psychiatry day program at Johns Hopkins University School of Medicine. “Aim to have the best life you can at where you are right now.”

August

Helping children exposed to trauma recover (audio) - KJZZ-FM (Tempe, Ariz.)
How do violent and traumatic experiences in childhood affect ... kids [in war-torn areas] as they grow up, and how can experts help them? With me to help answer those questions is Dr. Carolina Vidal. She's an assistant professor of psychiatry at Johns Hopkins University, specializing in child and adolescent psychiatry.

Research into marijuana benefits for vets with PTSD in danger of shutdown - Military Times
[The study] has faced numerous problems. Getting federal approval took five years. Officials at Johns Hopkins University in Maryland withdrew from the study shortly after its formal start, leaving [the principal investigator] with a single Arizona site to monitor participants.

California moves to become the first US state to legalise magic mushrooms - International Business Times (U.K.)
Psilocybin is considered a Schedule I drug by the California Controlled Substances Act and the US Drug Enforcement Agency (DEA). Drugs in this ranking have no accepted medical use and a high potential for dependence and abuse, according to the DEA.... However, a New York University study and a Johns Hopkins University research paper published late last year found that psilocybin helped ease anxiety and depression for some cancer patients.

Going deep with psychedelic therapy - Vice
Two years ago, after reading about a study carried out by Johns Hopkins University, which showed that psilocybin had an 80 percent success rate in smoking cessation, I decided to try it out for myself. With ... a handful of freshly picked magic mushrooms, I achieved in an afternoon what years of painful attempts to go cold turkey and abortive nicotine replacement courses had failed to do. I haven't touched – or even thought about – cigarettes since.

VA roadblock hinders study on cannabis as PTSD treatment for veterans, researcher says - The Cannabist (via Denver Post)
The study [to treat post-traumatic stress disorder] moved forward under MAPS [Multidisciplinary Association for Psychedelic Studies], and after receiving funding from Colorado, Johns Hopkins University joined the study in September 2015. However, in March the Baltimore university pulled out of the study without enrolling any veterans.... [A] dispute reportedly arose over federal drug policy, and whether to openly challenge federal rules on medical cannabis research.

Ecstasy could be ‘breakthrough’ therapy for soldiers, others suffering from PTSD - Washington Post
The next step was investigating MDMA’s effects on people. [Rick] Doblin again raised money to fly psychedelic users he had befriended to Stanford University and Johns Hopkins University for spinal taps. The studies were approved by review boards at both institutions.

How to lose weight? Get your brain under control - Boston Globe
“If you have an overweight mother, you’re more likely to become obese,” said Susan Carnell, the study’s author and an assistant professor at Johns Hopkins University’s Department of Psychiatry and Behavioral Sciences. “We were trying to see if there’s something different about the brain in students with a high risk of becoming obese later in life.”

Guns Play Oversize Role in Rural Suicides – New York Times
“Patients with mental health issues should be assessed for gun availability,” said the lead author, Dr. Paul S. Nestadt, a postdoctoral fellow at Johns Hopkins. “We give out condoms and clean needles to people at risk for H.I.V. Why not give out trigger locks to family members of patients at risk for suicide?”
Also covered by Kaiser Health News and Healthline

Montel Williams Shares His MS Treatment Story – WUSA
Features Dr. Adam Kaplin talking about depression in MS.

Researchers leverage PET and MR to uncover serotonin's role in Alzheimer's - Dotmed
“The study shows that the serotonin system is affected in the early stages before memory problems are severe enough to meet criteria for dementia,” Dr. Gwenn Smith, professor and director of geriatric psychiatry and neuropsychiatry at the university, told HCB News. “We hope the study will stimulate development of medications targeting the serotonin system for use in individuals at risk for dementia.”

Scans show lower brain serotonin levels linked to dementia - United Press International
Researchers at Johns Hopkins School of Medicine found that lower levels of serotonin transporter in the brain are linked to dementia. Serotonin transporter is the brain chemical responsible for appetite, sleep and mood.... Researchers examined brain scans of patients with early signs of memory decline and found that lower serotonin transporters may be the driving force of dementia, not a byproduct.
Also reported by: Yahoo News

Humanities in Healthcare - WYPR
How can the humanities be used to help doctors provide better care for their patients? Meg Chisolm, Associate Professor and Vice Chair for Education in the department of Psychiatry and Behavioral Sciences at Johns Hopkins Medicine, spoke about the BEAM (Bedside Education in the Art of Medicine) initiative (@BedEdArtMed).

Weed and depression: Does marijuana make for depressed brains? - U.S. News & World Report
While there is substantive evidence that pot increases the risk of psychotic disorders such as schizophrenia, the link to depression is unclear. “If there is an association, the data are not as robust as with psychotic illness. It’s just conjecture,” says Dr. Eric C. Strain, director of the Center for Substance Abuse Treatment and Research and professor of psychiatry and behavioral sciences at Johns Hopkins.

Psychedelic drugs saved my life. So why aren't they prescribed? - Wired
Roland Griffiths, a professor in the Departments of Psychiatry and Neurosciences at Johns Hopkins University in Maryland, has likened psychedelics' ability to bring about neural rerouting as akin to a "surgical intervention."

When addiction treatment means decades on Methadone – WYPR On Point
…according to Ken Stoller, a psychiatrist at Johns Hopkins Hospital who specializes in addiction psychiatry. For example, he said when Methadone is prescribed properly, there are no real long-term health risks — no more than there might be side effects with any medication. “This is one area of medicine where it seems like there’s more focus on opinion or philosophy as opposed to the science because the science is really, really clear on this,” Stoller said.

'I suffered from an eating disorder you've probably never heard of before' - Women's Health
Several studies ... including one from Johns Hopkins University, have identified [chewing and spitting] as a common behavior in individuals with anorexia, bulimia, and/or other eating disorders, and have suggested it may be a marker of disorder severity.

New Yorker shares tools he’s developed to overcome chronic pain in new book - am New York
[Jim] Curtis defines a “stimulati” as someone who “ignites passion, thought and wellness.” After 20 years seeking out everything from reiki to acupuncture to cryotherapy to treat his pain, he found his own stimulati. They include ... Adam Kaplin, a psychiatrist affiliated with Johns Hopkins Hospital, with whom Curtis created the anxiety-tracking app Mood 24/7, and career coach Denise Spatafora.

July

As dozens more report blackouts at Mexico resorts, country says it will act on tainted alcohol -Milwaukee Journal Sentinel
Matthew Johnson, an associate professor at Johns Hopkins School of Medicine, has no direct evidence, but the stories [about tainted alcohol] point to several likely possibilities: scopolamine, phencyclidine (better known as PCP) or methaqualone (quaaludes, a drug popular in the 1970s). Based on the many accounts vacationers described, any of those drugs seems to make sense, said Johnson, a specialist in behavioral pharmacology.
Also reported by: USA Today

How to improve your memory and brain health - AARP​
“The GCBH [Global Council on Brain Health] recommends people incorporate cognitively stimulating activities into their lifestyle to help maintain their brain health as they age,” says Marilyn Albert, chair of GBCH and director of the Division of Cognitive Neuroscience at Johns Hopkins University School of Medicine. “The sooner you start, the better because what you do now may make you less susceptible to disease-related brain changes later in life.”

In the context of the opioid crisis, doctors discuss the future of chronic pain treatment - KPCC-FM (Los Angeles)
Against the backdrop of the opioid crisis, we sit down with three doctors to explore the rise of opiates, and how pain treatment can move past them.… Among the guests: Michael Clark, M.D., vice chair for clinical affairs and director of the pain treatment program in the department of psychiatry and behavioral sciences at the Johns Hopkins Hospital.

Psychedelics like shrooms could address depression in a way that's fundamentally different from prescription drugs - Business Insider
[The] shrinking of the sense of self has been linked with long-lasting shifts in perspective — changes that appear to be related to a reduction in symptoms of depression and anxiety. That’s according to clinical trials of magic mushrooms’ active ingredient, psilocybin, in cancer patients at Johns Hopkins and New York University.

Challenging intake guidelines with Dr Graham Redgrave - The Eating Disorder Recovery Podcast 
Tabitha Farrar talks to Dr Graham Redgrave about the research done at Johns Hopkins looking into higher weights and a faster rate of refeeding patients with anorexia in an inpatient hospital setting. 

Are movies about eating disorders fundamentally uncinematic? - Pacific Standard magazine
[Dr. Angela Guarda, director of the Eating Disorders Program at the Johns Hopkins University, says] that filmmakers could emphasize that one recovers from an eating disorder — as most do — through treatment that helps patients create healthy eating habits.... She says that films would do well to also include plots where loved ones encourage a sufferer to get help, providing an audience with practical, helpful information.

Drug testing at raves & festivals could save lives - The Fix
“People would be safest not taking any street drugs at all, but if free, no-fault testing can reduce deaths and other catastrophic consequences, it may be a service worth having,” said Matthew Johnson, associate professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine.

Keith Conners, psychologist who set standard for diagnosing A.D.H.D., dies at 84 - New York Times
The field of child psychiatry was itself still young when Dr. Conners joined the faculty of the Johns Hopkins University School of Medicine in the early 1960s as a clinical psychologist.... Dr. Conners focused on a group of youngsters who were chronically restless, hyperactive and sometimes aggressive.

Clinical trial examines tramadol to treat opioid withdrawal - United Press International
Researchers at Johns Hopkins University have found the drug tramadol, when combined with other therapies, may be effective for treating opioid withdrawal. The results of the clinical trial, published in JAMA Psychiatry, showed tramadol extended-release suppressed withdrawal symptoms more than clonidine and was similar to buprenorphine, both drugs commonly used in opioid withdrawal.
Study also highlighted in NIH Office of Behavioral and Social Science Research website and newsletter.

Can psychoactive drugs help ministers be more effective? University researchers aim to find out - Christian Today
Pastors and priests are taking drugs – but it's all in the name of science. Scientists at Johns Hopkins University in Baltimore have enlisted two dozen religious leaders for a study in which they are given two doses of psilocybin, the active ingredient in 'magic mushrooms'. The idea is to see how a transcendental experience affects religious thinking and whether it makes them more effective in their work, according to The Guardian.
Also reported by: Scientific American

What happens when a rabbi, a priest and twenty two other religious leaders get high on magic mushrooms? - Daily Mail (U.K.)
Religious leaders are taking a psychedelic drug to study its effect on religious experience. Scientists have recruited 24 religious leaders from different faiths and practices to participate in the ongoing study at Johns Hopkins University in Baltimore, Maryland. The participants, who are anonymous, will be given doses of psilocybin, the active ingredient in psychedelic mushrooms.
Also reported by: The Guardian (U.K.)

Surprise: A large share of ‘Molly’ brought to music festivals doesn’t actually contain MDMA, Hopkins researchers say - Baltimore Fishbowl
A medical research team from the school, led by psychiatry and behavioral sciences professor Matthew Johnson, partnered up on a study with the nonprofit DanceSafe, which tested samples of concertgoers’ drugs for free (and without penalty) from July 2010 through July 2015.

The robot sex doll revolution may have some big downsides, experts warn - Vice
There’s no evidence to suggest that these dolls really help anybody, and experts are unconvinced. In fact, Johns Hopkins School of Medicine paraphilia researcher Peter Fagan told the Atlantic in 2016 that childlike sex dolls would likely lead would-be pedophiles to act upon their urges “with greater urgency.”

The fine art of mental illness: What paintings tell us about someone’s psyche - Washington Post and numerous subscribers
James C. Harris, a professor of psychiatry and behavioral science and director of Johns Hopkins University’s Developmental Neuropsychiatry Clinic, spent more than a decade writing monthly essays that connect the visual arts to larger issues of psychiatry and mental illness. Now, those essays and the art that inspired them have been collected by the journal JAMA Psychiatry.

My Time: Lecture combines clinical research with powerful personal narratives - Baltimore Sun
Around 80 people, many of whom are clinical professionals, attended the lecture hosted by Chesapeake Life Center and held May 3 at the Meeting House in Columbia. The first speaker, Dr. D. Andrew Tompkins, an assistant professor in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine, shared his research on opioid use disorders and their treatments. Also reported by: Capital Gazette

June

Here's how much Fitbit users sleep - PC magazine
"These findings further support the general recommendation that most adults need to consistently sleep 7 to 9 hours per night, and illustrate why a good night's rest is so important for your overall well-being," Fitbit advisory panel sleep expert Michael T. Smith, Jr., Ph.D., professor of psychiatry, neurology, and nursing at Johns Hopkins University School of Medicine in Baltimore, said in a statement.

How People With Dementia Can Live at Home Longer – Next Avenue
The MIND program makes a difference, saving money for families and Medicaid
Quincy Samus, an assistant professor at Johns Hopkins who leads the MIND at Home research team, is conducting two more studies of the program. One, through a $6.4 million innovation grant from the Centers for Medicare and Medicaid Services, focuses on low-income older adults and their caregivers. The other, funded with $3.4 million from the National Institute on Aging, looks at participants of all income levels. Both studies will gain insight into the program’s costs and long-term sustainability. Combined, they involve 647 people with dementia and an equal number of family members in central Maryland.

How people with dementia can live at home longer - Forbes
[The Gerben family] got a boost from a program in Maryland called Maximizing Independence (MIND) at Home. [It was] designed in 2006 by dementia specialists at Johns Hopkins University and offered to families as part of Johns Hopkins research that is still ongoing.

 What a ‘transcendent experience’ really means - New York magazine
[O]ne day in 2008, [Janeen Delaney] learned about a study at Johns Hopkins University looking at people facing imminent death. The research team, led by psychiatrist Roland Griffiths, wanted to know whether having a major transcendent experience — induced by psilocybin, the active ingredient in so-called magic mushrooms — would help people like Janeen face death with peace rather than despair.... Janeen signed up.

Alzheimer's patients need special care, but providers aren't ready to give it - Healthcare Dive
Older people with Alzheimer’s have twice as many hospital stays per year as other older Americans…. “People with Alzheimer’s really need a lot of care,” Dr. Kostas Lyketsos, professor of psychiatry and behavioral sciences at Johns Hopkins Medicine, told Healthcare Dive.

9 things to consider when your antidepressant poops out - Everyday Health
Rule out noncompliance. This seems like a no-brainer, but according to Kay Redfield Jamison, Ph.D., a professor at Johns Hopkins School of Medicine, the biggest challenge professionals face in treating bipolar disorder ... is medical adherence. Approximately 40 to 45 percent of bipolar patients do not take their medications as prescribed.

After Mission bust, hemp oil producer to make no-THC products for Kansas - Kansas City Star
Ryan Vandrey, a psychiatry professor at Johns Hopkins University who has studied the effects of cannabis, said it’s hard to pin down how much low-THC hemp oil one would have to consume to have a psychoactive effect. But he said it’s a lot, and most law enforcement agencies haven’t done much to crack down on it, in part because “the hemp law is a little bit confusing.”

Caffeine is a silent performance killer - Huffington Post
New research from Johns Hopkins shows that performance increases due to caffeine intake are the result of caffeine drinkers experiencing a short-term reversal of caffeine withdrawal. By controlling for caffeine use in study participants, Johns Hopkins researchers found that caffeine-related performance improvement is nonexistent without caffeine withdrawal.

The new way to prevent anxiety in kids - Time
Researchers at the University of Connecticut and Johns Hopkins University tested an eight-week therapy for healthy kids who each had at least one parent with an anxiety disorder. During the following year, 31% of kids who didn’t receive the therapy developed an anxiety disorder, whereas only 5% of kids who received treatment developed one.

The VA admits pot could help veterans, but doctors still can't prescribe medical marijuana - Circa
In March, Johns Hopkins University pulled out of a marijuana PTSD study due to a dispute over federal drug policy and whether to challenge federal rules requiring researchers to only use medical cannabis grown by the National Institute on Drug Abuse.

Michael Phelps added to Medibio board of directors - Swimming World
According to a press release put out by Medibio, an evidence-based medical technology company located in Australia, Michael Phelps has been added to the organization’s Board of Directors.... Medibio’s depression diagnostic is being validated in clinical studies undertaken by Johns Hopkins University School of Medicine and The University of Ottawa, among others.

May

Seniors and depression: Not a normal part of aging - U.S. News & World Report
Dr. Susan W. Lehmann, clinical director of the division of geriatric psychiatry and neuropsychiatry and director of the Geriatric Psychiatry Day Hospital at Johns Hopkins University School of Medicine: “Depression is never considered a normal part of aging,” she says. “While the more of life we live, the more likely we are to experience times of sadness and grief related to loss or change, most people handle these life challenges without developing a persistent depressive disorder.”

The long, hard road to a science of bad drug trips - Motherboard/Vice
[The] renewed interest in psychedelic harm reduction has increasingly attracted individual researchers running psychedelic studies at various research institutions around the world. At the forefront of these psychedelic studies is Johns Hopkins University, which has been pioneering research into the therapeutic potential of psilocybin, the psychoactive component of magic mushrooms, for the last few years.

Alcohol and depression: A risky combination - U.S. News & World Report
[H]aving a mental illness makes treating substance dependence much more difficult. “The dilemma for those with depression is that a drug that produces a transient elevation of mood may make the person think, 'This is helpful,'” says Dr. Eric C. Strain, director of the Center for Substance Abuse Treatment and Research and professor of psychiatry and behavioral sciences at Johns Hopkins University.

Adult ADHD can't be diagnosed with a simple screening test, doctors warn​ (audio) - NPR and numerous subscribers
Dr. David Goodman, an ADHD specialist at Johns Hopkins University and the Adult Attention Deficit Disorder Center of Maryland, [says] that not everyone who experiences the symptoms of ADHD necessarily suffers from the disorder, and that a simple screening test cannot diagnose it.​​

Magic mushrooms might be the "safest" recreational drug, but they're still risky - Mashable
Two recent studies at New York University and Johns Hopkins University found that psilocybin — a key compound in the mushrooms — has promising therapeutic benefits for people with depression. Proponents are seeking to legalize mushrooms for use in controlled, medical settings.

Bipolar disorder dating tips - Teen Vogue
According to Kay Redfield Jamison, Ph.D., a clinical psychologist and professor of psychiatry at the Johns Hopkins University School of Medicine, who both has and studies bipolar illness, the average age of onset is around 22. But some people experience symptoms earlier — right about when they are starting to date.

Magic mushrooms might be the "safest" recreational drug, but they're still risky - Mashable
Two recent studies at New York University and Johns Hopkins University found that psilocybin — a key compound in the mushrooms — has promising therapeutic benefits for people with depression. Proponents are seeking to legalize mushrooms for use in controlled, medical settings.

The truth about 'Blue Whale,' an online game that tells teens to self-harm - Motherboard
Dr. Shannon Barnett, assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, told Motherboard in an email that while this game exemplifies the risk of someone taking advantage of youth who are emotionally distressed, there is no one reason for adolescents to feel so bad that they have suicidal thoughts and/or thoughts of harming themselves.

Bipolar disorder dating tips - Teen Vogue
According to Kay Redfield Jamison, Ph.D., a clinical psychologist and professor of psychiatry at the Johns Hopkins University School of Medicine, who both has and studies bipolar illness, the average age of onset is around 22. But some people experience symptoms earlier — right about when they are starting to date.

Sex workers who use LSD have lower suicide risk, study finds - The Globe and Mail (Canada)
There is a growing body of research into the benefits of psychedelic drugs. In 2014, researchers at Johns Hopkins University in Baltimore reported that some long-time smokers who had failed many attempts to quit did so successfully while receiving magic mushrooms, in the context of a cognitive behavioral therapy treatment program. 

This is how much caffeine it takes to kill an average person - USA Today and numerous affiliates
[T]he limit varies from person to person, says Maggie Sweeney, a postdoctoral research fellow at Johns Hopkins School of Medicine's department of psychiatry. "For adults it would be uncommon to experience effects of caffeine intoxication at less than 250 milligrams of caffeine (or 2.5 cups of coffee)," she said. "...It would typically be more than 12 ounces, but much more common to have the negative effects with greater than 500 milligrams of caffeine."

Psychedelic drugs: The future of mental health - Reason
A recent study found that MDMA-assisted therapy could help veterans suffering from PTSD. Another paper from Johns Hopkins presented evidence that therapy in conjunction with psilocybin mushrooms can help ease the mental suffering of terminal cancer patients. These findings, among others, were presented at the 2017 Psychedelic Science Conference in Oakland, California.

How a man's near-death with cancer inspired him to fund LSD research - Inc.
[E]ntrepreneur Rodrigo Niño has launched Fundamental, a crowdfunding platform that allows people to fund psychedelic research in an effort to develop FDA-approved therapies.... The psychedelic renaissance was jumpstarted by Roland Griffiths, a professor of behavioral biology at Johns Hopkins, in 2006 when he published an influential paper about the meaningful spiritual experiences patients go through while on psilocybin.

Can psychedelic drugs treat mental illness? Scientists need your help to find out. - Huffington Post
This past December ... researchers at [New York University and] Johns Hopkins University published the results of two separate clinical trials on the effects of psilocybin-assisted psychotherapy on patients with cancer-related anxiety and depression. All told, between 60 and 80 percent of the subjects showed clinically significant reductions in both psychological disorders after treatment.

Researchers will soon evaluate risks, benefits of self-medicating with small doses of LSD - Mashable
Two concurrent studies at New York University and Johns Hopkins University found that psilocybin — a key compound in hallucinogenic mushrooms — can help ease existential depression in people with life-threatening cancer, specifically when taken in a controlled setting and combined with therapy.

Is a placebo better than nothing to treat insomnia? - Reuters
Beyond the small number of total participants, another limitation of the current study is that researchers didn’t have objective measurements of sleep quality or duration to compare placebos against no treatment, the authors note in Sleep Medicine. Still, the results make sense because insomnia is ultimately a disorder of perception, said Patrick Finan, a psychiatry and behavior researcher at Johns Hopkins University School of Medicine in Baltimore.

A doorway to change - Psychology Today
At Johns Hopkins, psychiatrist Matthew Johnson led a 2014 pilot study of 15 longtime smokers treated with psilocybin and had found that 80 percent abstained from smoking six months after the trial — an especially compelling result as nicotine dependence is often thought to be primarily physiological....

One family's journey through a mental health crisis - Today
In a Q&A, Dr. Jennifer Payne, a noted researcher and clinician who directs the Women's Mood Disorder Clinic at Johns Hopkins Hospital, tells Today both medicine and society still have a ways to go in the treatment of mental illness.

Can psychedelic drugs treat anxiety and depression? - Men's Health
Psychedelics are again finding favor among scientists. NYU Langone isn't alone: Teams at institutions as varied as Imperial College London, the University of Alabama, and Johns Hopkins are currently studying them.

Know the warning signs of suicide - WBAL-TV
Following a segment on a new Netflix show that focuses on a teenage girl’s suicide, Dr. Holly Wilcox, a professor of psychiatry and behavioral sciences at Johns Hopkins, expresses concern that the show discusses suicide in an irresponsible and graphic way and suggest that if parents want to allow their children to watch it, they should watch it with them.

April

Psychedelic drugs might actually tap into a higher power (study) - Inverse
“It’s our thought that the foundational underpinnings of the world’s religions may stem from a common sense of unity and interconnectedness, and that perhaps there’s something very similar about them,” says Johns Hopkins psychologist Dr. Roland Griffiths, lead author of the study. 

‘Higher state of consciousness’ from psychedelics is not just a hippie idea — it’s biological - The Fix
As for psilocybin, the active ingredient in magic mushrooms, research from scientists at NYU Langone Medical Center and Johns Hopkins University have found it to be an effective tool for treating depression and anxiety in terminally ill individuals.

What happens if you smoke marijuana every day? - USA Today and numerous subscribers
Dr. Ryan Vandrey, an associate professor at Johns Hopkins Medicine, says you can't generalize marijuana users. Other factors need to be considered, such as their dosage and the reason a person is using the drug. However, he said marijuana can have impact on how people perform at their job or at school. Withdrawal can occur after a period of long-term repeated use.

JCS Partners with Hopkins on Innovative Dementia Study – Baltimore Jewish Times
More than 10 years ago, the late philanthropist LeRoy E. Hoffberger sought to improve the lives of people living at home with dementia and the lives of their caregivers. Together, Hoffberger and Dr. Constantine Lyketsos, director of Johns Hopkins Memory and Alzheimer’s Treatment Center, brainstormed on what became the MIND at Home: Memory Care Coordination studies. (MIND stands for Maximizing Independence)

Howard County's shortage of affordable housing for mentally ill undermines stability* - Baltimore Sun
Demand for Howard County General Hospital's inpatient psychiatric unit is increasing, according to a hospital spokesperson. A new psychiatric unit is part of the plans for a new two-story addition to the hospital, along with a larger expanded emergency unit and a new pediatric emergency unit.

The ayahuasca ceremony is going under the scientific-method microscope - Quartz
[R]ather than playing the sacred songs which are said to influence the effects of the ayahuasca, the researchers are considering using the same recorded music that is used in the psilocybin trials at Johns Hopkins and New York universities. 

Judge sees a boy, not a disorder - Baltimore Sun
One man sees a child suffering from a psychological disorder. The other sees a young civil rights leader. The sharply contrasting opinions of two prominent men from Baltimore – one a former chief psychiatrist at Johns Hopkins Hospital, the other a senior judge of the federal appeals court in Richmond — appear in the case of Gavin Grimm….

The Federal Government Makes It Ridiculously Hard to Study Gun Violence and Medical Marijuana - Scientific American
“It can't come off of Schedule I to a different schedule until the traditional drug development work has been done, and I don't think the traditional drug development work [large phase III trials] really can be done while it's Schedule I,” said Ryan Vandrey of the Johns Hopkins University School of Medicine on February 19 at the AAAS conference. “It's a catch-22.”

New research on treatment for pediatric bipolar disorder focus of UC Davis lecture - UC Davis Health
Robert Findling. Findling is the director of the Division of Child and Adolescent Psychiatry and vice chair in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins. He is also the vice president for Psychiatric Services and Research at the Kennedy Krieger Institute.

The Innovating, Creative Superpowers of ADHD - Yes Magazine
Dr. David Goodman, assistant professor of the Department of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine, explained how a person can have an IQ of 140 or 80 and have ADHD.

5 ways to help a partner who's suffering from mild depression -  Prevention
Instead of reacting negatively to a thought or a feeling about your partner's depression (i.e. "why do you never want to go to the movies?") try asking a question that will make him or her feel like their feelings are valid, suggests Lauren Osborne, MD, assistant director of the Women's Mood Disorders Center at the Johns Hopkins University School of Medicine. Something like, "I notice you have been really irritable and down lately, do you want to talk?"

Hopkins to resume gender reassignment surgeries - Washington Blade
In a little-noticed development, Johns Hopkins Hospital in Baltimore disclosed last July that it would open a new Center for Transgender Health and will resume performing gender reassignment surgeries after a 38-year hiatus.... “We will wait until we are fully staffed and officially open, probably this summer, before we plan any proactive outreach on the new Center for Transgender Health,” [a spokeswoman for] Johns Hopkins Medicine told the Washington Blade in an email.

Can trans people trust Johns Hopkins’s new clinic? - Daily Beast
[I]n a new statement to The Daily Beast ... a Johns Hopkins Medicine spokesperson stated: “Johns Hopkins Medicine has and is taking steps toward becoming an employer and provider of choice for all, including transgender individuals. And statements or actions to the contrary by current or former affiliates of Johns Hopkins do not reflect our institution’s current views. We are committed to being a caring, inclusive place for all patients, families and employees.”

The problem with America's marijuana DUI laws: Science - Reno Gazette Journal
While it would seem logical to model drugged driving laws after existing drunken driving laws, marijuana is a tricky substance. “Alcohol is the exception. Alcohol is the only drug that we can immediately determine whether someone is acutely impaired on the roadside,” said [Dr. Ryan Vandrey, associate professor of behavioral pharmacology research at Johns Hopkins University]. “There are lots of drugs that we don’t have reliable tests for – cannabis is the normative.”

March

I Saw The Light: Reducing anxiety, stress, depression, more with shrooms – City Paper
Nearly four decades after research into psychedelics was suppressed by the government, a new wave of scientists is restoring legitimacy to a misunderstood and promising area of research. Baltimore is home to arguably the most prestigious psychedelic research program in the world. The studies conducted by Roland Griffiths and his team at Johns Hopkins University School of Medicine did not just commence this new era of legally sanctioned research; they are also the most rigorous scientific studies to date on psilocybin.

Hopkins was ready to test pot as a treatment for PTSD. Then it quit the study. - Washington Post and subscribers
Eighteen months after joining a study on using marijuana to treat post-traumatic stress disorder, Johns Hopkins University has pulled out without enrolling any veterans, the latest setback for the long-awaited research. A Johns Hopkins spokeswoman said the university’s goals were no longer aligned with those of the administrator of the study, the Santa Cruz-based Multidisciplinary Association for Psychedelic Studies (MAPS). Also reported by: The Cannabist, Weed Weekly

Do You Zone Out? Procrastinate? Might Be Adult ADHD - NPR Shots

"It's very important to look at the questions in their totality, not each individual symptom," says Dr. David Goodman, an assistant professor of psychiatry at Johns Hopkins School of Medicine who was not involved in the study. "No single question stands out as indicating ADHD."

Social Media Is Causing Depression Among Teen Girls - MSN
A "steady stream of research" suggests that far more girls than boys are battling major depression in their almost-adult years — and the growing psychological dependence on Snapchat, Facebook, Instagram and other social media may be making young women more vulnerable to mental illness. Ramin Mojtabai’s research is mentioned.

Baltimore's spot in the history of psychotherapy* (audio) WYPR-FM
As the American Association for Psychoanalysis in Clinical Social Work gathered [in Baltimore] this past weekend, [WYPR talked]  to two therapists [including Daniel Buccino, assistant professor in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine and a clinical supervisor in the community psychiatry program at Johns Hopkins Bayview Medical Center] about Baltimore’s special spot in the development of psychoanalysis, the challenges for therapists and residents in a city suffused with trauma….

The sublime psychology of Baltimore - Baltimore Sun
This opinion piece that looks at Baltimore’s "tender and tough, wounded and surviving, swaggering and fearful, Northern and Southern, black and white" psychology was co-written by Daniel Buccino, clinical director of the Mood Disorders Clinic at Johns Hopkins Bayview Medical Center.

Why some women may be more biologically susceptible to postpartum depression - Shape
Researchers estimate that only 15 percent of women who are affected [by postpartum depression] get treatment. That's why we're stoked to see the latest research coming from Johns Hopkins University. It shows that having high levels of an anti-anxiety hormone throughout pregnancy — especially the second trimester — may protect soon-to-be-moms against PPD.

How tripping kills your fear of dying, and why that could change your life - The Rooster
Matthew W. Johnson is a researcher at Johns Hopkins who has the interesting job of giving magic mushrooms to dying people. In one recent study, with FDA approval and university funding, Johnson got 51 cancer patients [high] on mushrooms, and 80 percent of them said it helped them feel more optimistic and less scared of death.

Why the clinical use of psychedelics may heal sexual trauma - Psychology Today
Research on such chemicals as psilocybin (the psychoactive ingredient in "magic mushrooms") and MDMA ("ecstasy") are now in Phase 3 FDA-approved trials, with significant preliminary results. Psilocybin research at Johns Hopkins University and NYU, for example, have found that patients with terminal cancer experienced a reduction in mortality related depression and anxiety and heightened levels of well-being.

Forgiveness … the ultimate freedom - W4CY radio (West Palm Beach, Fla.)
More and more though it is being found that ... feelings [of hurt, anger and resentfulness] negatively impact our health: “There is an enormous physical burden to being hurt and disappointed,” says Karen Swartz, M.D., director of the Mood Disorders Adult Consultation Clinic at The Johns Hopkins Hospital. "Forgiveness, however, calms stress levels, leading to improved health.”

The psychedelic miracle - Rolling Stone
Currently – legally – we're in the midst of a psychedelic renaissance. New York University, the University of New Mexico, the University of Zurich, Johns Hopkins University, the University of Alabama and the University of California-Los Angeles have all partnered with the psilocybin-focused Heffter Research Institute, studying the compound for smoking cessation, alcoholism, terminal-cancer anxiety and cocaine dependence....

February

Hope you’re ready for the next episode - Boulder Weekly (Colorado)
[P] is getting attention for proving very (very) effective in treating notoriously difficult to treat conditions like end-of-life anxiety, chronic depression and addiction. As just one example, in a 2016 study performed by Johns Hopkins University School of Medicine ... it was reported that 80 percent of patients showed “large decreases in clinician and self-rated measures of depressed mood and anxiety, along with increases in quality of life, life meaning, and optimism, and decreases in death anxiety.” Six months later the results were sustained without further treatment.  

Could a club drug be the secret to curing PTSD? - Elle
Other psychedelics [besides MDMA] are also yielding promising lab results, including psilocybin (the active ingredient in so-called magic mushrooms), which teams of researchers from Johns Hopkins and New York University found can reduce anxiety and depression in cancer patients.

'River on Fire' explores genius, madness and the poetry of Robert Lowell - NPR and numerous affiliates
Kay Redfield Jamison's new book describes how Lowell's manic-depressive illness influenced his life and work. "His manias tended to lead him into writing a fresh kind of poetry," she says.... She's a professor in mood disorders and psychiatry at the Johns Hopkins University School of Medicine.

Senior Nation: The Science of Forgetfulness with Dr. Constantine Lyketsos (video)
Chestertown Spy (Eastern Shore)
On March 8, the Talbot Hospice will be sponsoring a lecture by one of the leading experts in dementia and Alzheimer’s disease at Easton High School. Dr. Lyketsos, from the [Johns] Hopkins department of psychiatry and behavioral sciences, will address these issues and the devastating effects of the illness, but also promising new treatments. The Spy traveled to Baltimore to sit down with Lyketsos before the event for a primer on dementia and memory loss.

Why having sex on cocaine can be dangerous - Esquire
Cocaine makes people do risky [stuff], and science has long tracked the increased risk of cocaine users contracting STIs. But the reason was never scientifically clear. A new, government-funded (!) study from Johns Hopkins, however, found that cocaine use not only increases sexual desire, but it makes that sex more dangerous. 

Can all suicides be prevented in an inpatient facility like St. Joe's?CBC (Canada)
Dr. Geetha Jayaram is quoted.

Kay Redfield Jamison puts Robert Lowell on the couch in a fascinating biography - Washington Post
Jamison contends that “instability and the relentless recurrence of [Lowell's] illness hardened his discipline while mania impelled and stamped his work.” To establish her diagnosis, this distinguished professor of psychiatry at the Johns Hopkins School of Medicine and author of the best-selling memoir “An Unquiet Mind” brings to bear everything she can think of.

The Rise of Mood Tracking: How Big Data Can Transform Psychiatry – Reach MD
Dr. Adam Kaplin, founder and inventor of Mood 24/7, discusses the emergence of mood tracking portals and how they can transform mental health care.

Worrying about your grown kids really can keep you up at night - Reuters
[S]ome parents who worry excessively about their adult children might benefit from therapy to improve coping skills or minimize stress, said Dr. Patrick Finan, a researcher in psychiatry and behavioral health at Johns Hopkins University School of Medicine in Baltimore who wasn't involved in the study.

Marijuana as medicine? Weed study exploring clinical trials on military veterans with post traumatic stress disorder - International Business Times
Participants will finish 17 outpatient visits to one of the two study location clinics — one in Phoenix, led by Dr. Sue Sisley, and another at Johns Hopkins University in Baltimore, led by Ryan Vandrey. The team will be tracking measurements of PTSD, PTSD symptoms and safety data to dig for “vital information on marijuana dosing, composition, side effects, and areas of benefit to clinicians and legislators considering marijuana as a potential treatment for PTSD. ”

Cocaine users are more likely to have sexually transmitted diseases – for this reason
The Telegraph (U.K.)
People who regularly use cocaine are more likely to have sexually transmitted diseases than non-users. According to a new study by researchers at the Johns Hopkins University School of Medicine, this may in part be due to a "sexual-impatience" brought on by the drug which increases the likelihood that users will not bother to use condoms. Also reported by: Inverse, Med India

Can LSD treat depression? Microdosing in the mainstream - WTOP-AM
When routine therapies and medications failed to help Ayelet Waldman overcome intense mood swings and a deep depression, she turned to something that is generally associated with harm, not health: LSD. Waldman heard about microdosing, or taking tiny doses of drugs, thanks to its growing presence in the media. Researchers at Johns Hopkins and New York universities have studied the impact of psychedelic drugs on cancer patients for anxiety.

Marijuana anxiety? Here's what to do if you have a panic attack while high - Mic
Can weed cause panic attacks? "It can," said Ryan Vandrey, who studies the behavioral pharmacology of cannabis use at Johns Hopkins University School of Medicine, in a phone interview. "It happens from direct effects of the drug in the brain and/or direct effects of the drug on body."

January

The potentially dangerous effect cocaine can have on your sex life
Cosmopolitan
A study by the Johns Hopkins University School of Medicine in Baltimore, United States has discovered a correlation between people who use cocaine and the increased risk of catching and spreading STIs.

Is the Mediterranean diet good for kids, too?
CNN
For parents who would like to introduce a Mediterranean diet into their children's daily eating routine, Dr. Carolina Vidal, an assistant professor of psychiatry and behavioral sciences at Johns Hopkins Medicine, offered a few tips. "Slowly introduce fruits and vegetables, and present them consistently with the other foods they eat.

(Yes, it’s possible to have too much caffeine (and these are the caffeine overdose symptoms to look for)
Health
Life-threatening incidents of caffeine overdose are fortunately extremely rare, says Maggie Sweeney, PhD, a postdoctoral research fellow at the Johns Hopkins University School of Medicine who studies caffeine. "It would be very difficult to get to a lethal dose of caffeine through consuming coffee," she explains. "[Coffee] sort of has preventive measures because it is difficult to consume that volume of liquid."

Treatment can help turn around opioid abuse (video)
WBAL-TV
"I used Percocet for four or five years. When that became too expensive, I switched to heroin," [Ashley] Stuart said. "I lost my storage, my car, my house and my job." With that loss, Stuart sought help at the Johns Hopkins Broadway Center for Addiction, where she goes for buprenorphine treatments and gets extensive counseling. The center's director, Dr. Kenneth Stoller, said treatment is what this opioid epidemic needs.

FDA clears Lurasidone (Latuda) for schizophrenia in adolescents* (study)
Medscape
"The impact on development and poor prognosis frequently associated with schizophrenia that begins in adolescence underscores the need for treatment that is both well-tolerated and effective," Robert Findling, MD, vice president, psychiatric services and research, Kennedy Krieger Institute, and director of child and adolescent psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, and a study investigator, said in the release. "The availability of Latuda provides healthcare providers with an important new option for helping adolescents with this illness…." added Dr Findling.

Hit the hay: Three reasons why good sleep is crucial for mental health
Psych Central
One in three American adults don’t get enough sleep. Though Johns Hopkins Medicine reports that as many as ninety percent of North Americans respond to this chronic lack of sleep with a regular dose of caffeine, that little pick-me-up doesn’t cut it.

Magic mushrooms as mental health treatment
U.S. News & World Report
[Sherry] Marcy learned about an ongoing study at Johns Hopkins University using psilocybin for cancer patients with persistent, treatment-resistant depression. Marcy, who had never tried psychedelic drugs recreationally – she didn't disapprove; it just wasn't her thing – experienced her first drug trip as a study volunteer.

Hallucinogens: Future of mental health treatment?
WebMD
Matthew Johnson, PhD, a research psychologist at Johns Hopkins University, says he’d be surprised if hallucinogenic drugs didn’t have a proper medical use “under some constrained, limited circumstances.” “Most powerful substances that we know of, that have powerful effects on the central nervous system, are like any powerful tool,” says Johnson, who has studied how psilocybin affects depression. “They can have dangerous effects, or beneficial effects...."

I didn’t believe I had an eating disorder. But the threat of forced feeding saved my life
Stat
“Those of us who have treated 1,000 plus patients know that we are bad at predicting who will recover and have seen recovery in some of the most severely ill and chronic cases, even in cases who failed multiple treatments,” [Angela Guarda, director of the eating disorders program at Johns Hopkins University] said in an email. “There is much danger in viewing anorexia as a terminal illness. Instilling hope and helping patients find a path to recovery should always be our goal.”

Why psychedelics like magic mushrooms kill the ego and fundamentally transform the brain
Business Insider
On a chilly December morning, [Clark] Martin walked into the facility at Johns Hopkins, where he was greeted by two researchers, including Bill Richards, a psychologist. The three of them [went] over the details of [a] study and what might happen. Martin received a pill and swallowed it with a glass of water. For study purposes, he couldn't know whether it was a placebo or psilocybin, the drug the researchers aimed to study.

How LSD saved one woman’s marriage
New York Times
Researchers at institutions like New York University and Johns Hopkins have yielded promising results administering psilocybin to cancer patients to relieve anxiety, combat obsessive-compulsive disorder and even treat addiction to other drugs.

Researchers are giving religious leaders hallucinogenic drugs to understand mystical experiences
Business Insider
In recent weeks we've heard more and more about the resurgence in psychedelic research, with scientists from Johns Hopkins and New York University talking about how hallucinogenic psilocybin could work "like a surgical intervention for mental illness."

Religious leaders are experimenting with psychedelics for scientific purposes
Esquire
The indescribable high, intense emotions, and intimate sense of self experienced under the influence of magic mushrooms are similar to another kind of trip: a religiously mystical experience. So, as science naturally muses, let's give shrooms to deeply religious people and see what happens. That's how [13 religious leaders] started taking psilocybin, the active ingredient in magic mushrooms, at Johns Hopkins University and New York University.

LSD, yoga, and the therapeutic process of ‘ego dissolution’
New York magazine
A Johns Hopkins study last year found that psilocybin helped people who had been smoking a pack a day for decades quit at double the success rate of the best pharmaceutical treatments. “Our data does indicate that stronger mystical experiences are associated with success,” lead author Matthew Johnson told Science of Us.

Researchers are feeding priests psychedelic drugs in the interest of science
Quartz
[R]esearchers have found consistent overlap between mystical experiences that occur naturally and those that are caused by psilocybin. “All we’re doing is finding conditions that increase the likelihood of these mystical experiences, and we still don’t know their ultimate cause,” says Roland Griffiths, a principal investigator across multiple Johns Hopkins psilocybin trials.

back to top button